Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
doi:10.1016/s0378-5122(02)00321-3 Vanuytsel T, van Wanrooy S, Vanheel H, et al
Retatrutide is not just a stronger version of semaglutide or tirzepatide
Generation 2 Dual GLP-1/GIP Agonists (Tirzepatide) Tirzepatide was the first dual-agonist incretin peptide to reach advanced clinical research
The team will guide you through the next steps, including any insurance information needed and whether preliminary laboratory testing should be ordered
At 24 weeks, mean percentage decrease in weight (primary outcome) ranged from 7.2% to 17.5% with different retatrutide doses compared with 1.6% with placebo
US$ 23.79
US$ 29.62
US$ 26.44
US$ 26.12
US$ 27.83
US$ 20.87
US$ 25.63
US$ 25.06
